ON-DEMAND WEBINARS

Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.

In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).

Explore how AI‑powered search, intelligent data capture, and ontology‑driven structure streamline scientific discovery and documentation, as well as how structured data unlocks smarter analysis.

Listen in as Chief Product Officer Jim Nichols, Product Manager Jim Horstmann, and VP Solutions Consulting Aaron Grant discuss issues and solutions for trial master files.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

John Oncea Editor